Senate stopgap funding bill would push back federal hemp THC prohibition to Dec. 11

A Senate government funding stopgap package would include language delaying a federal ban on most hemp-derived THC products until Dec. 11, according to The Hill. The provision would affect products that contain THC derived from hemp, which are currently regulated under a patchwork of federal and state rules.

The request to postpone the prohibition was incorporated into a bill designed to keep federal agencies funded while Congress works on broader legislation, the report said. The specific delay would extend the window in which most hemp THC products could remain legally sold under existing federal law and related enforcement approaches, rather than facing a new nationwide prohibition on the previously scheduled timeline.

Hemp industry groups and product makers have sought relief from the impending federal change, arguing that enforcement timelines and product compliance requirements should be addressed through additional federal action, the report said. The proposed delay, if adopted, would shift implementation of the ban by more than a month from its originally described start date.

The bill is expected to be considered in the Senate this week, The Hill reported. Procedural action on stopgap spending measures can proceed quickly, with opportunities for amendments and limited debate depending on the chamber’s schedule.

Opponents of the hemp THC market generally have argued that limiting or prohibiting products with psychoactive THC characteristics is necessary for public health and consumer safety, while supporters have emphasized that federally regulated hemp programs permit controlled THC production. The report did not include detailed text or findings supporting either side, but it framed the legislative move as a stopgap solution for the industry ahead of the scheduled prohibition.

If the delay language is enacted and becomes law, the practical effect would be to push back the start of the federal prohibition on most hemp-derived THC products to Dec. 11. Congressional action after Senate consideration would determine whether the provision survives final passage, including reconciliation with any companion House legislation and the bill’s final signature status.